EventsProhibition Partners Live Returns For Its Second Virtual Outing...

Prohibition Partners Live Returns For Its Second Virtual Outing Of 2020


PROHIBITION Partners LIVE is back for its second outing this year with more than 1,500 delegates set to attend the virtual event.

Running from November 17 to 20, Prohibition Partners LIVE will feature some of the industry’s leading lights over four days of virtual networking, conversations and debate.

Stephen Murphy, Managing Director of Prohibition Partners, said: “There has never been a time where the demand for cannabis has been higher, from record sales to groundbreaking research being released, the future of cannabis looks very bright.

“Despite a pending recession, cannabis will remain one of the few true growth industries, and that should be of interest to investors and governments alike.

“Having received such a rapturous reception with our inaugural conference in June, with over 1,500 delegates joining to share ideas, spark innovation and promote change, we couldn’t wait to be back.

“We believe that cannabis has the power to change the world for the better and in such a rapidly moving industry which requires constant education, regulatory clarity and international collaboration and Prohibition Partners LIVE offers the building blocks for this incredible community.”

Each day will see thought-leaders and innovators deep-dive into key sectors within the industry: 

November 17: Science & Research
November 18: Policy & Reform
November 19: Business & Investment
November 20: Culture & Innovation

As well as the theme days, running in parallel will be a number of key tracks including Cannabis Europa, Cannabis Americana, Cannabis Oceania and PSYCH, which looks at unlocking the commercial potential of psychedelics.

A fifth track, ProCapital, sponsored by Mazakali, is an investment-focused platform, showcasing opportunities across the cannabis and psychedelics landscape.

For further information and discounted tickets click on this link.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you